D. Bugembe, My V.T.Phan, I. Ssewanyana, Patrick Semanda, Hellen Nansumba, B. Dhaala, S. Nabadda, Á. O'toole, A. Rambaut, P. Kaleebu, M. Cotten
medRxiv, 2021
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first detected in March 2020 in Uganda. Recently the epidemic showed a shift of SARS-CoV-2 variant distribution and we report here newly emerging A sub-lineages, A.23 and A.23.1, encoding replacements in the spike protein, nsp6, ORF8 and ORF9, with A.23.1 the major virus lineage now observed in Kampala. Although the clinical impact of the A.23.1 variant is not yet clear it is essential to continue careful monitoring of this variant, as well as rapid assessment of the consequences of the spike protein changes for vaccine efficacy.
Cited by 30 publications.
Field of study: Medicine